Atossa Therapeutics to Present at the Maxim Growth Summit 2025

Invites New Investors to Learn More About $ATOS SEATTLE, Oct. 15, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing new approaches in breast cancer treatment and prevention, announces that...